Published date: 8 April 2024
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£46,600,000
Procurement reference
CF-2286900D0O000000rwimUAA
Published date
8 April 2024
Closing date
3 January 2024
Closing time
1pm
Contract start date
1 March 2024
Contract end date
28 February 2025
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Project Title: NHS National Framework for Tocilizumab - March 2024
Offer reference number: CM/PHR/23/5702
CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
More information
Attachments
-
- PARTIES APPOINTED TO THE FRAMEWORK AGREEMENT CM-PHR-23-5702 Tocilizumab.docx
- PARTIES APPOINTED TO THE FRAMEWORK AGREEMENT CM-PHR-23-5702 Tocilizumab
-
- Document No. 03 - Framework Agreement and Terms and Conditions.pdf
- Document No. 03 - Framework Agreement and Terms and Conditions
-
- Document No.10 - Pharmacy Purchasing Points CM-PHR-23-5702.xlsx
- Document No.10 - Pharmacy Purchasing Points CM-PHR-23-5702
-
- Transparency Award Schedule - CM_PHR_23_5702.pdf
- Transparency Award Schedule - CM_PHR_23_5702
-
- 231129 - FTS 2023S 000-035227 - NHS National Framework for Tocilizumab - March 2024 - Find a Tender.pdf
- 231129 - FTS 2023S 000-035227 - NHS National Framework for Tocilizumab - March 2024 - Find a Tender
Award information
Awarded date
11 March 2024
Contract start date
1 March 2024
Contract end date
28 February 2025
Total value of contract
£46,600,000
This contract was awarded to 2 suppliers.
Roche Products Ltd
Address
Hexagon Place 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW
Reference
None
Supplier is SME?
No
Fresenius Kabi Limited
Address
Cestrian Court, Eastgate Way, Manor Park,, Runcorn, Cheshire,, WA7 1NT
Reference
None
Supplier is SME?
No
About the buyer
Contact name
Katie Noonan
Address
NHS England
Runcorn, Cheshire,
WA7 2ES
GB
Share this notice
Closing: 3 January 2024, 1pm
All content is available under the
